SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]:
SEC Accession No. 0001558370-19-001798
Filing Date
2019-03-12
Accepted
2019-03-11 18:28:03
Documents
62
Period of Report
2018-12-31

Document Format Files

Seq Description Document Type Size
1 10-K btai-20181231x10k.htm 10-K 2519136
2 EX-31.1 btai-20181231ex311123d32.htm EX-31.1 12849
3 EX-31.2 btai-20181231ex31282fe1f.htm EX-31.2 13670
4 EX-32.1 btai-20181231ex321c9b3da.htm EX-32.1 8337
5 EX-32.2 btai-20181231ex3226beb22.htm EX-32.2 8366
6 GRAPHIC btai20181231x10k001.jpg GRAPHIC 153926
7 GRAPHIC btai20181231x10k002.jpg GRAPHIC 32809
8 GRAPHIC btai20181231x10k003.jpg GRAPHIC 22641
9 GRAPHIC btai20181231x10k004.jpg GRAPHIC 23002
10 GRAPHIC btai20181231x10k005.jpg GRAPHIC 230580
  Complete submission text file 0001558370-19-001798.txt   6513598

Data Files

Seq Description Document Type Size
11 EX-101.INS btai-20181231.xml EX-101.INS 830216
12 EX-101.SCH btai-20181231.xsd EX-101.SCH 39053
13 EX-101.CAL btai-20181231_cal.xml EX-101.CAL 40602
14 EX-101.DEF btai-20181231_def.xml EX-101.DEF 125667
15 EX-101.LAB btai-20181231_lab.xml EX-101.LAB 347146
16 EX-101.PRE btai-20181231_pre.xml EX-101.PRE 259203
Mailing Address 555 LONG WHARF DRIVE NEW HAVEN CT 06511
Business Address 555 LONG WHARF DRIVE NEW HAVEN CT 06511 203-643-8060
BioXcel Therapeutics, Inc. (Filer) CIK: 0001720893 (see all company filings)

IRS No.: 821386754 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-K | Act: 34 | File No.: 001-38410 | Film No.: 19673445
SIC: 2834 Pharmaceutical Preparations
Office of Life Sciences